Compare StocksAMGN vs MS

Amgen Inc. (AMGN) vs Morgan Stanley (MS): Which Is the Better Buy in 2026?

As of 2026-09-17, AMGN is overvalued at $378, with a DCF intrinsic value of $313 and a margin of safety of -21%. MS is undervalued at $202, with an intrinsic value of $303 and a margin of safety of 33%. Of the two, MS has the wider margin of safety.

AMGN
Amgen Inc.
$378.29
VS
MS
Morgan Stanley
$202.02

Rewards

AMGN
  • Gross margin of 71.9% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Amgen Inc. scores 73/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
  • Return on equity has consistently exceeded 20% over 4 years, indicating efficient use of shareholder capital.
MS
  • Gross margin of 87.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.

Risks

AMGN
  • ROIC has declined by 7.7 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 2.30 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • High leverage (3.71x net debt/equity) combined with thin interest coverage (-1.0x) poses financial risk.
MS
  • Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • Insiders have sold $5.4M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
AMGN
MS
Valuation
$8.65B
Free Cash Flow
N/A
4.23%
FCF Yield
N/A
23.48
Trailing P/E
16.31
15.50
Forward P/E
14.81
Quality & Moat
15.51%
ROIC
3.53%
91.47%
ROE
17.97%
71.89%
Gross Margin
87.64%
2.30
PEG Ratio
1.82
Balance Sheet Safety
3.71
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.51
Net Debt / EBITDA
N/A
2.68%
Dividend Yield
2.27%
AMGN: 3Ties: 2MS: 4
AMGNMS

Historical Fundamentals

Learn more →
AMGN

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
AMGN
$9.01
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$4.01B
Δ Market Cap
+$36.10B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
AMGN
20.8% Overvalued
Price is 20.8% above estimated fair value
Current Price: $378.29
Fair Value: $313.10
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MS
33.3% Margin of Safety
Price is 33.3% below estimated fair value
Current Price: $202.02
Fair Value: $303.09
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
AMGN

What growth rate is the market pricing in at $378?

+9.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +12.6%

The market implies +9.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +12.6%, reflecting heavy growth investment.

MS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
AMGN
73/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by reinvestment efficiency. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
AMGN
-2.24
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
AMGN
Insiders 0.2%Institutions 85.0%Retail & Other 14.8%
No. of Institutional Holders3,999
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MS
Insiders 24.4%Institutions 63.2%Retail & Other 12.4%
No. of Institutional Holders3,488
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
AMGN
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
MS
0
Buys (3M)
1
Buys (12M)
Total value (12M): $5,630
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
AMGN
3
Sells (3M)
9
Sells (12M)
Total value (12M): $29.33M
KHOSLA RACHNA
Officer
$1.35M
@ $414.05 · 2026-08-13
GRYGIEL NANCY A
Officer
$1.19M
@ $402.16 · 2026-08-06
MILLER DEREK
Officer
$1.57M
@ $402.54 · 2026-08-06
GRYGIEL NANCY A
Officer
$400,451
@ $323.73 · 2026-05-04
SANTOS ESTEBAN
Officer
$20.77M
@ $379.12 · 2026-02-26
BUSCH MATTHEW C.
Officer
$375,790
@ $375.79 · 2026-02-19
GRYGIEL NANCY A
Officer
$1.06M
@ $337.26 · 2025-11-20
KHOSLA RACHNA
Officer
$299,256
@ $336.24 · 2025-11-12
GORDON MURDO
Officer
$2.32M
@ $336.83 · 2025-11-12
GRYGIEL NANCY A
Officer
$376,280
@ $296.99 · 2025-08-20
KHOSLA RACHNA
Officer
$434,520
@ $289.68 · 2025-06-05
BUSCH MATTHEW C.
Officer
$279,690
@ $279.69 · 2025-05-02
REESE DAVID M.
Chief Technology Officer
$10.23M
@ $301.56 · 2025-02-21
MILLER DEREK
Officer
$593,934
@ $293.45 · 2025-02-19
SANTOS ESTEBAN
Officer
$2.55M
@ $292.84 · 2025-02-19
GORDON MURDO
Officer
$2.59M
@ $294.79 · 2025-02-11
GRAHAM JONATHAN P
General Counsel
$7.34M
@ $293.12 · 2025-02-07
GRYGIEL NANCY A
Officer
$483,808
@ $304.47 · 2025-02-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MS
2
Sells (3M)
14
Sells (12M)
Total value (12M): $64.71M
SCHAPIRO MARY L
Director
$212,055
@ $212.06 · 2026-07-28
PIZZI MICHAEL A
Officer
$5.21M
@ $215.55 · 2026-07-17
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
AMGN
FearGreed
😐Neutral(45/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MS
FearGreed
😐Neutral(52/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
AMGN
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (45)
MS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
View AMGN Full AnalysisView MS Full Analysis

Frequently Asked Questions: AMGN vs MS

Is Amgen Inc. or Morgan Stanley more undervalued in 2026?

Based on our discounted cash flow model, MS trades at a 33.3% margin of safety (intrinsic value $303 vs. price $202), compared to AMGN's -20.8% margin of safety (intrinsic $313 vs. $378).

Which stock has a wider economic moat, Amgen Inc. or Morgan Stanley?

MS scores 80/100 (Wide moat), while AMGN scores 73/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. AMGN scores 1.7 (Distress zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Amgen Inc. or Morgan Stanley?

AMGN earns 15.5% ROIC versus MS's 3.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Amgen Inc.'s or Morgan Stanley's?

MS's dividend earns a safety score of 79/100 (Safe), compared to AMGN's 69/100 (Safe). MS has raised its dividend for 3 consecutive years.